Spots Global Cancer Trial Database for nivolumab injection
Every month we try and update this database with for nivolumab injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation | NCT03146468 | Haematological ... | Nivolumab Injec... | 18 Years - | Melbourne Health | |
| Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months | NCT03298893 | Cervical Cancer Locally Advance... | Nivolumab Injec... Cisplatin radiotherapy | 18 Years - 99 Years | Institut Curie | |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| The IMmunotherapy Pleural 5-ALA PDT | NCT04400539 | Mesotheliomas P... Malignant Pleur... | intrapleural ph... Nivolumab Injec... | 18 Years - | University Hospital, Lille | |
| Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors | NCT04165330 | Solid Tumor, Ad... Soft Tissue Sar... Non Small Cell ... Small Cell Lung... | AL3818 Nivolumab Injec... | 18 Years - | Sarcoma Oncology Research Center, LLC | |
| Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months | NCT03298893 | Cervical Cancer Locally Advance... | Nivolumab Injec... Cisplatin radiotherapy | 18 Years - 99 Years | Institut Curie | |
| Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors | NCT04165330 | Solid Tumor, Ad... Soft Tissue Sar... Non Small Cell ... Small Cell Lung... | AL3818 Nivolumab Injec... | 18 Years - | Sarcoma Oncology Research Center, LLC | |
| Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma | NCT03918252 | Mesothelioma | Nivolumab Injec... Ipilimumab Inje... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| The IMmunotherapy Pleural 5-ALA PDT | NCT04400539 | Mesotheliomas P... Malignant Pleur... | intrapleural ph... Nivolumab Injec... | 18 Years - | University Hospital, Lille | |
| Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma | NCT04021420 | Melanoma Metastatic Mela... | SONOCLOUD Nivolumab Injec... | 18 Years - | Assistance Publique - Hôpitaux de Paris |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
